|
US6572862B1
(en)
|
1989-11-08 |
2003-06-03 |
Baylor College Of Medicine |
Methods and reagents to detect and characterize Norwalk and related viruses
|
|
AU1893592A
(en)
|
1991-03-25 |
1992-10-21 |
Board Of Trustees Of The Leland Stanford Junior University |
Norwalk virus human gastroenteritis agent and molecular cloning of corresponding cdnas
|
|
JPH07509122A
(ja)
|
1992-04-08 |
1995-10-12 |
ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ，アズ レプリゼンテッド バイ ザ セクレター，デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
野生型麻疹ウイルス糖タンパク質：ワクチンおよびその検出方法
|
|
AU4851493A
(en)
|
1992-09-07 |
1994-03-29 |
Baylor College Of Medicine |
Methods and reagents to detect and characterize norwalk and related viruses
|
|
EP0689454B2
(en)
|
1993-03-23 |
2005-02-23 |
SMITHKLINE BEECHAM BIOLOGICALS s.a. |
Vaccine compositions containing 3-o deacylated monophosphoryl lipid a
|
|
US5788970A
(en)
|
1994-03-29 |
1998-08-04 |
The University Of Maryland College Park |
Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon
|
|
BR9507657A
(pt)
|
1994-05-16 |
1997-09-09 |
Merck & Co Inc |
Proteina isolada e purificada de papilomavirus recombinante capsideos particulas semelhantes a virus processos a virus processos para produzir a proteina para tratar ou prevenir a infecçao por papilomavirus para produzir uma proteina de capsideo de papilomavirus recombinante montada em um capsideo ou particula semelhante a virus e para induzir uma resposta imune em um animal vertebrado composiçoes farmacêuticas kit para a detecçao de papilomavirus ou anticorpos para papilomavirus e sistema sinte
|
|
US5645051A
(en)
|
1995-04-21 |
1997-07-08 |
Dura Pharmaceuticals, Inc. |
Unit dose dry powder inhaler
|
|
US5861241A
(en)
|
1995-08-16 |
1999-01-19 |
University Of Massachusetts |
Monoclonal antibodies for detecting Norwalk virus
|
|
GB9525083D0
(en)
|
1995-12-07 |
1996-02-07 |
Danbiosyst Uk |
Vaccine compositions
|
|
US5834015A
(en)
*
|
1996-09-11 |
1998-11-10 |
Albany Medical College |
Protein-lipid vesicles and autogenous vaccine comprising the same
|
|
US5953727A
(en)
|
1996-10-10 |
1999-09-14 |
Incyte Pharmaceuticals, Inc. |
Project-based full-length biomolecular sequence database
|
|
US6491919B2
(en)
|
1997-04-01 |
2002-12-10 |
Corixa Corporation |
Aqueous immunologic adjuvant compostions of monophosphoryl lipid A
|
|
SK138199A3
(en)
|
1997-04-08 |
2000-06-12 |
Merck & Co Inc |
Human papillomavirus antigen formulation and method for stabilizing a population of virus-like purified particles, derived from protein l1 or protein l1 and l2 of human papillomavirus
|
|
CA2288129A1
(en)
|
1997-05-01 |
1998-11-12 |
Chiron Corporation |
Use of virus-like particles as adjuvants
|
|
US20040265377A1
(en)
|
1997-10-27 |
2004-12-30 |
Harry Seager |
Solid dispersing vaccine composition for oral delivery
|
|
BR9913026A
(pt)
|
1998-08-14 |
2001-09-25 |
Merck & Co Inc |
Processo de purificação de partìculas semelhantes a vìrus (vlps) de papilomavìrus recombinante, e, processo de preparação de um produto de vlp de papilomavìrus humano purificado adequado para uso em uma vacina para humano
|
|
CA2354444A1
(en)
|
1998-12-17 |
2000-06-22 |
Merck & Co., Inc. |
Synthetic virus-like particles with heterologous epitopes
|
|
SI1150712T1
(sl)
|
1999-02-05 |
2009-02-28 |
Merck & Co Inc |
Pripravek cepiva proti humanem papiloma virusu
|
|
KR100771402B1
(ko)
|
1999-06-22 |
2007-10-30 |
국립감염증연구소장이 대표하는 일본국 |
Ｓｒｓｖ 검출 킷트
|
|
JP2002020399A
(ja)
|
2000-07-10 |
2002-01-23 |
Osaka Prefecture |
ノルウォークウイルス（ｎｖ）を認識するモノクローナル抗体
|
|
GB0118249D0
(en)
|
2001-07-26 |
2001-09-19 |
Chiron Spa |
Histidine vaccines
|
|
WO2003068933A2
(en)
|
2002-02-14 |
2003-08-21 |
Novavax, Inc. |
Optimization of gene sequences of virus-like particles for expression in insect cells
|
|
GB0206360D0
(en)
|
2002-03-18 |
2002-05-01 |
Glaxosmithkline Biolog Sa |
Viral antigens
|
|
GB0206359D0
(en)
|
2002-03-18 |
2002-05-01 |
Glaxosmithkline Biolog Sa |
Viral antigens
|
|
EP1494651A4
(en)
|
2002-04-11 |
2010-10-13 |
Medimmune Vaccines Inc |
PRESERVATION OF BIOACTIVE MATERIALS WITH FREEZZED FOAM
|
|
GB0302218D0
(en)
|
2003-01-30 |
2003-03-05 |
Chiron Sri |
Vaccine formulation & Mucosal delivery
|
|
EP1545625B1
(en)
|
2002-06-07 |
2011-08-24 |
Kentucky Bioprocessing, LLC |
Flexible vaccine assembly and vaccine delivery platform
|
|
PL375306A1
(en)
|
2002-06-20 |
2005-11-28 |
Cytos Biotechnology Ag |
Packaged virus-like particles for use as adjuvants: method of preparation and use
|
|
JP4675317B2
(ja)
|
2003-01-30 |
2011-04-20 |
ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド |
アジュバント化インフルエンザワクチン
|
|
US20040213745A1
(en)
|
2003-02-20 |
2004-10-28 |
Vincent Sullivan |
Powder formulations of rSEB for improved vaccination
|
|
US8592197B2
(en)
|
2003-07-11 |
2013-11-26 |
Novavax, Inc. |
Functional influenza virus-like particles (VLPs)
|
|
WO2005032457A2
(en)
|
2003-07-21 |
2005-04-14 |
Boyce Thompson Institute For Plant Research, Inc. |
Vectors and methods for immunization against norwalk virus using transgenic plants
|
|
WO2005030806A2
(en)
|
2003-09-24 |
2005-04-07 |
Montana State University |
Norovirus monoclonal antibodies and peptides
|
|
US7795242B2
(en)
|
2003-10-15 |
2010-09-14 |
The Brigham And Women's Hospital, Inc. |
Methods and compositions for immunomodulation
|
|
US20050215501A1
(en)
|
2003-10-24 |
2005-09-29 |
Coley Pharmaceutical Group, Inc. |
Methods and products for enhancing epitope spreading
|
|
FR2863890B1
(fr)
|
2003-12-19 |
2006-03-24 |
Aventis Pasteur |
Composition immunostimulante
|
|
US7481997B1
(en)
|
2004-02-12 |
2009-01-27 |
Montana State University |
Snow mountain virus genome sequence, virus-like particles and methods of use
|
|
US20050260225A1
(en)
|
2004-05-18 |
2005-11-24 |
Goldberg Joanna B |
Intranasal recombinant Salmonella vaccine encoding heterologous polysaccharide antigens
|
|
CU23496A1
(es)
|
2004-09-03 |
2010-02-23 |
Ct Ingenieria Genetica Biotech |
Composición vacunal contra el virus de la hepatitis c
|
|
JP4993301B2
(ja)
|
2004-10-20 |
2012-08-08 |
サノフィ パスツール バイオロジクス リミテッド ライアビリティ カンパニー |
日本脳炎ウイルスおよび西ナイルウイルスに対するワクチン
|
|
GB0428394D0
(en)
|
2004-12-24 |
2005-02-02 |
Chiron Srl |
Saccharide conjugate vaccines
|
|
RU2007129840A
(ru)
|
2005-01-05 |
2009-02-20 |
Филадельфия Хелт Энд Эдьюкейшн Корпорейшн Д/Б/А Дрексел Юниверсити Колледж Оф Медисин (Us) |
Средства доставки, биологически активные вещества и вирусные вакцины
|
|
US8168771B2
(en)
|
2005-01-31 |
2012-05-01 |
The Johns Hopkins University |
Use of consensus sequence as vaccine antigen to enhance recognition of virulent viral variants
|
|
NZ580974A
(en)
|
2005-02-18 |
2011-05-27 |
Novartis Vaccines & Diagnostic |
Immunogens from uropathogenic escherichia coli
|
|
US7767212B2
(en)
|
2005-03-18 |
2010-08-03 |
Cytos Biotechnology Ag |
CAT allergen conjugates and uses thereof
|
|
KR20080018176A
(ko)
|
2005-06-01 |
2008-02-27 |
다우 글로벌 테크놀로지스 인크. |
다가 바이러스 유사 입자 생산 방법
|
|
EP1736538A1
(en)
|
2005-06-21 |
2006-12-27 |
Cytos Biotechnology AG |
Process for the preparative purification of virus-like-particles (VLPs)
|
|
JP5215865B2
(ja)
|
2005-11-22 |
2013-06-19 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス インコーポレイテッド |
ノロウイルス抗原およびサポウイルス抗原
|
|
JP2007145775A
(ja)
|
2005-11-29 |
2007-06-14 |
Falco Life Science:Kk |
ノロウイルスｇｉの高感度検出方法
|
|
US20080029915A1
(en)
*
|
2006-08-02 |
2008-02-07 |
Courtoy Nv |
Rotary tablet press
|
|
HUE032422T2
(en)
*
|
2006-09-29 |
2017-09-28 |
Takeda Vaccines Inc |
Norovirus vaccine preparations
|
|
CN101553252A
(zh)
|
2006-12-06 |
2009-10-07 |
诺华有限公司 |
包含来自于四株流感病毒的抗原的疫苗
|
|
CA2683977C
(en)
*
|
2007-03-14 |
2017-04-25 |
Ligocyte Pharmaceuticals, Inc. |
A method of norovirus virus-like particle purification comprising ion exchange chromatography
|
|
US8648229B2
(en)
|
2007-09-12 |
2014-02-11 |
Australian Centre For Plant Functional Genomics Pty Ltd |
Plant seed active transcriptional control sequences
|
|
US20100266636A1
(en)
*
|
2007-09-18 |
2010-10-21 |
Ligocyte Pharmaceuticals, Inc. |
Method of conferring a protective immune response to norovirus
|
|
SG10201601660YA
(en)
|
2007-09-18 |
2016-04-28 |
Takeda Vaccines Inc |
Method of conferring a protective immune response to norovirus
|
|
AU2009279456B2
(en)
|
2008-08-08 |
2015-02-05 |
Takeda Vaccines, Inc. |
Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity
|
|
EP2381959A1
(en)
*
|
2009-01-22 |
2011-11-02 |
Pharmathene Inc. |
Stable vaccine compositions and methods of use
|
|
WO2010092476A1
(en)
*
|
2009-02-10 |
2010-08-19 |
Novartis Ag |
Influenza vaccine regimens for pandemic-associated strains
|
|
US20110070260A1
(en)
|
2009-09-09 |
2011-03-24 |
Baric Ralph S |
Multivalent Immunogenic Compositions Against Noroviruses and Methods of Use
|
|
SG182636A1
(en)
|
2010-01-21 |
2012-08-30 |
Ligocyte Pharmaceuticals Inc |
Targeted heterologous antigen presentation on calicivirus virus-like particles
|
|
WO2011150258A1
(en)
*
|
2010-05-26 |
2011-12-01 |
Selecta Biosciences, Inc. |
Dose selection of adjuvanted synthetic nanocarriers
|
|
EA029470B1
(ru)
|
2011-07-11 |
2018-03-30 |
Такеда Вэксинс, Инк. |
Способ стимулирования формирования защитного иммунитета против норовируса
|
|
JOP20130186B1
(ar)
|
2012-06-22 |
2021-08-17 |
Takeda Vaccines Montana Inc |
تنقية الجزيئات الشبيهة بالفيروسات
|
|
EP3389695A4
(en)
|
2015-12-16 |
2019-10-09 |
The Walter and Eliza Hall Institute of Medical Research |
INHIBITION OF CYTOKININDUCED SH2 PROTEIN IN NK CELLS
|
|
EP4338799A3
(en)
|
2016-10-18 |
2024-06-05 |
Regents of the University of Minnesota |
Tumor infiltrating lymphocytes and methods of therapy
|
|
CN112292390A
(zh)
|
2018-05-03 |
2021-01-29 |
得克萨斯大学体系董事会 |
经工程改造以在免疫检查点阻断的情况下表达嵌合抗原受体的自然杀伤细胞
|
|
WO2020041192A1
(en)
|
2018-08-20 |
2020-02-27 |
Takeda Vaccines, Inc. |
Vlp formulations
|
|
AR117462A1
(es)
|
2018-12-20 |
2021-08-04 |
Takeda Vaccines Inc |
Vacuna contra norovirus, formulaciones y métodos
|
|
KR20210129105A
(ko)
|
2019-02-15 |
2021-10-27 |
에디타스 메디신, 인코포레이티드 |
면역치료법을 위한 변형된 자연 살해(nk) 세포
|